본문 바로가기
KERD
논문KCI 등재

항혈소판제제에 따른 뇌경색 환잔의 혈소판 응집력의 차이

The Difference of Platelet Aggregability in Patients with Cerebral Infarction accordigng to Type of Anti-platelet Agents

박경원|김상호|김재우|신현철|차재관|천상명|윤고운
대한신경과학회 (Korean Neurological Association)|2004.02|대한신경과학회지 (Journal of the Korean Neurological Association)|제22권 제1호|pp. 11-15

2

조회

0

다운로드

2

인용

0

참고문헌

주제분류신경과학

초록

Abstract

Platelets play a key role in many occlusive vascular disorders and anti-platelet agents are the most important therapeutic strategy in preventing the recurrence of cerebral infarction. In order to know the platelet aggregability according to the strategy of anti-platelet agents, we measured platelet aggregability in patients who were taking anti-platelet agents for cerebral infarction. Methods: Platelet aggregability in response to adenosine diphosphate (ADP) or collagen was measured in whole blood samples from 175 patients (48 females and 137 males). It was analyzed according to the type of cerebral infarction, vascular risk factors, and each anti-platelet agent. Results: Platelet aggregability induced by ADP or collagen was significantly increased in patients with large artery atherosclerotic infarction compared to those with small vessel disease. Among anti-platelet regimens, combined therapy with aspirin and clopidogrel decreased platelet aggregability most effectively. Conclusions: These findings suggest that anti-platelet treatment should be tailored to the vascular status of each patient, and that combination therapy with aspirin and clopidogrel can effectively modulate platelet aggregability in preventing the recurrence of cerebral infarction

참고문헌 (25)

  1. "Platelet activation mechanisms and markers in arterial thrombosis", 239, pp.17~34 (1996)
  2. "Atherosclerosis", 407, pp.233~241 (2000)
  3. "Prevention of ischemic stroke antiplatelets", 56, pp.510~525 (2000)
  4. "Circulating platelets show increased activation in patients with acute cerebral ischemia", 81, pp.373~377 (1999)
  5. "The change of platelet aggregation with large artery atherosclerotic infarction", 21, pp.14~19 (2003)
  6. "Progresssive vascular damage in hypertension is associated with increased levels of circulatin P-selectin", 16, pp.45~50 (1998)
  7. "Changes in platelet glycoprotein receptors after smoking- a flow cytometric study", 12, pp.20~26 (2001)
  8. "Significance of chemokines and activated platelets in patients with diabetes", 121, pp.437~443
  9. "Activated platelets in patients with severe hypertriglyceridemia: effects of triglyceride lowering therapy", 152, pp.407~414 (2000)
  10. "comparison of Impedance and optical method for evaluation of platelet aggregation", 12, pp.428~435 (1994)
  11. "The inhibitory effect of ticlopidine to platelet aggregation", 12, pp.436~443 (1994)
  12. "Effect of triflusal on platelet aggregation in human whole blood", 15, pp.60~66 (1997)
  13. "Anti-aggregatory effect of anti-platelet agents", 9, pp.286~296 (1991)
  14. "Ensuring reliability of outcome measures in multicenter clinical trials of treatments for acute ischemic stroke. The program developed for the Trial of Org 10172 in Acute Stroke Treatment (TOAST)", 25, pp.1746~1751 (1994)
  15. "Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank", 32, pp.2559~2566 (2001)
  16. "Analysis of 1,129 consecutive patients with acute stroke: The Hallym Stroke Registry", 1, pp.21~27 (1999)
  17. "Comparison of risk factors for lacunar infarcts and territorial infarcts", 1, pp.35~41 (1999)
  18. "Possible existence of platelet activation before the onset of cerebral infarction", 153, pp.203~207 (2000)
  19. "Current oral antiplatelet agents to prevent atherothrombosis", pp.11(suppl 2)11~17 (2001)
  20. "CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke", 349, pp.1641~1649 (1997)
  21. "The International Stroke Trial (IST) a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke", 349, pp.1569~1581 (1997)
  22. "Changes of platelet activation and clinical outcome in acute atherosclerotic infarction treated with clopidogrel loading dose (300 mg)", 21, pp.128~133 (2003)
  23. "The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease", 21, pp.2033~2041 (2000)
  24. "Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronaryintervention: the PCI-CURE study", 358, pp.527~533 (2001)
  25. "Ischemic stroke subtypes; a population- based study of functional outcome, survival, and recurrence", 31, pp.1062~1068 (2000)

관련 논문AI추천

동맥경화성 뇌경색 환자들에서 90일간의 혈소판 활성도의 연속적 변화김상호, 김재우, 박경원, 박민정, 오영미, 차재관대한신경과학회 · 대한신경과학회지2003 · 제21권 제4호신속혈소판기능검사를 이용한 허혈성 뇌졸중 환자에서 아스피린 저항성의 빈도와 관련인자 - 예비연구김태형대한뇌졸중학회 · 대한뇌졸중영문학회지2006 · 제8권 제1호뇌졸중 환자의 시기에 따른 평균 혈소판 요소의 변화복수경, 오상향, 윤종명, 이종욱, 조경자, 홍준형대한재활의학회 · Annals of Rehabilitation Medicine2005 · 제29권 제1호허혈성 뇌졸중 환자에서 신속혈소판기능 검사를 이용한 클로피도그렐의 혈소판 응집 억제 반응 측정김재국, 김형일, 신혜은, 이보람, 이수주, 전종은대한신경과학회 · 대한신경과학회지2008 · 제26권 제4호허혈성 뇌졸중 환자에서 클로피도그렐과 티클로피딘의 혈소판기능검사고영채, 김재국, 김진옥, 김효정, 오건세, 윤동준, 이상준, 이수주, 조성래대한신경과학회 · 대한신경과학회지2011 · 제29권 제3호The Difference in Aspirin Resistance Based on an Optical Platelet Aggregometer and the PFA-100 in Patients with Acute Ischemic Stroke김대현, 김해종, 박향일, 유남태, 차재관, 최재형, 허재택대한뇌졸중학회 · 대한뇌졸중영문학회지2011 · 제13권 제3호

이 간행물의 다른 논문 (9건)

한국의 유전성 대사장애 질환이홍진pp. 1-10노인에서 연령에 따른 혈압과 인지기능의 관계권순석, 정슬기, 손명호, 김재민, 손의주, 신민호, 조기현, 남해성pp. 16-21알쯔하이머병의 진행 정동에 따른 행동심리적 증상의 변화김태유, 김상윤, 김재우, 박경원, 유봉구, 이상찬pp. 34-39아밀로이드베타단백(Aβ1-42) 투여 후 신경아세포의 보체 C3a수용체와 C5a수용체의 발현최영숙, 감상호, 이광수pp. 52-58거대세포 동맥염과 연관된 뇌경색 1예정두신, 안무영, 양광익, 안병준, 박형국pp. 59-62
원문 보기